University Hospital of Geneva, Department of Anesthesiology
Geneva, 1211, Switzerland
NCT Number: NCT02625701
There is no ideal "cookbook recipe" for fluid prescription that would fit every surgical patient.
In this study, the investigators working hypothesis is that the adoption of an integrative algorithm for perioperative fluid and haemodynamic management would improve clinical outcome and reduce hospital resource utilization in noncardiac surgical procedures (major-to-intermediate level of stress.
Two intraoperative fluid strategies will be compared: "Restrictive" vs. "goal-directed therapy (GDT)". In the GDT group, haemodynamic information will be obtained by a flow monitoring device coupled with standard heart rate and blood pressure monitoring.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Geneva, 1211, Switzerland
The rationale of minimizing body weight gain and avoiding unnecessary fluid compensation of the "third compartment" is now well justified and achievement of supra-normal oxygen delivery values is likely not necessary in most surgical patients. Therefore,it would be tempting to adopt fluid restriction protocols given the potentials of better wound healing, faster return of bowel function and shorter hospital stay after major surgical procedures.
Although dynamic flow indices of volume responsiveness have been validated in critically-ill patients, concerns have been raised regarding the risk of overzealous fluid administration in non-critically-ill patients undergoing elective surgery.
To date, RCTs comparing fluid regimen ("liberal" versus "restrictive" or "liberal" versus "GDT") have yielded controversial results with no consensus regarding appropriate fluid administration in the perioperative period. Interestingly, restrictive protocols have been associated with more frequent adverse events (e.g., nausea, vomiting) following minor surgical procedures and concerns have been raised regarding the possibility of tissue hypoperfusion leading to end-organ dysfunction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Optimize CO with additional fluid according to dynamic indices (PPV, SVV, Stroke volume)
Other names: GDT
Keep normovolemia with basal crystalloids infusion (3-6 ml/kg/h) and compensate additional fluid losses with colloids or crystalloids.
Time frame: from date of surgery till hospital discharge or 30-day postoperative
early postoperative major outcomes: mortality, cardiovascular, respiratory, renal and infectious complications
Time frame: from date of surgery till hospital discharge, or 30-day postoperative
comparison of body weight (preop versus postop value, kg)
Time frame: intra-operative and first 24hours after surgery
amount of fluids (ml) infused, amount of fluid losses
change in body weight
Time frame: from the day before to 3 days after surgery
measurements of creatinine (preoperative, postoperative day 1, 2, 3 after surgery) and assessing the changes in glomerular filtration rate (%)
Time frame: from date of surgery till hospital discharge, up to 15 weeks after date of surgery
scoring the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems
Time frame: intraoperative period, day of surgery
Monitoring of oxygen delivery/utilization in the brain area with near-infra-red spectroscopy (NIRS)
Time frame: survival 1-3 years after surgery
patients (family, next of kin, doctor) are contacted by phone or mail
University Hospital, Geneva
Other
Perioperative Fluid Management: Goal-Directed Therapy vs. Restrictive Approach, a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03598413
Atrophy, Colonic Diseases
Guildford, Surrey, United Kingdom
View Trial DetailsNCT03012984
Agnosia, Analgesia
Beijing, Beijing Municipality, China
View Trial DetailsNCT03881891
Complication, Postoperative, Neurologic Manifestations
San Francisco, California, United States
View Trial DetailsNCT04026438
Complication, Postoperative, Pathologic Processes
New Delhi, India
View Trial Details